Sign in
4

Changes in Ownership

ACADIA PHARMACEUTICALS INC Filed Acc 0001209191-22-002751

EVP, COO, Head of Commercial sold 538 shares at $23.05 ($12,401)

  • EVP, COO, Head of Commercial acquired 1,286 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Teehan Brendan EVP, COO, Head of Commercial 2022-01-06 Option exercise +1,286 2,326 D
Teehan Brendan EVP, COO, Head of Commercial 2022-01-06 Sale −538 $23.05 $12,401 1,788 D
Derivatives
Teehan Brendan EVP, COO, Head of Commercial 2022-01-06 Option exercise · Restricted Stock Units −1,286 2,573 D
Open-market sales · 538 sh · avg $23.05 · $12,401
Loading xslF345X03/doc4.xml…